LadRx Corp (LADXD)

[knoxlube]

Ya think? lol! BUT, "ASAP" is the perfect deadline for SK/SOON since it's so ambiguous and vague. It leaves them both with all kinds of "wiggle room". I have been digging deeper into a couple of other small cap pharma stocks trading on NASDAQ that suffered recent significant drops in their pps due to some problem with their trial data and/or the FDA, and none of them seem as solid as CYTR. Neither financially (Have huge debt) nor clinically (no NDA filings), and yet both were trading MUCH higher than CYTR before their drop, and continue to trade at a higher pps (one in particular).

Bottom line, IMO, CYTR is GREATLY undervalued!! If we knew for a fact that Soon had already filed the NDA for Aldox as a "stand alone" drug, what would pps be? What if Aldox was approved, what would pps be? Not to mention milestone payments? We have to believe that the clinical data on Aldox, presented to investors is true, and that Doc Soon got the deal of the century! If aldox works as well in Soon's cocktails and/or as a stand alone drug as he obviously believes, we'll certainly benefit, GREATLY! When and how much remain the questions? SOONer or LADR!

And yes, I'm anxious to see that next ER also. At least it will give everyone something else to talk about unless we get "ASAP" SOONER! lol!

GL 2 US ALL & CYTR!